Can PrEP work for people who use drugs? new study aims to find out
NCT ID NCT07385183
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how to help people who use drugs start and keep taking PrEP, a daily pill that prevents HIV. Researchers will follow 200 participants from the emergency department for one year, tracking who stays on the medication and what helps or hinders them. They will also interview doctors and peer workers to understand barriers. The goal is not to test if PrEP works—that's already proven—but to find real-world solutions for this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Descovy (F/TAF)
What this could lead to
If successful, this could show practical ways to improve HIV prevention in a high-risk group that often struggles with access and adherence.
What could go wrong
This is an observational study, not a test of the drug's effectiveness. It may not lead to changes in care if barriers are too complex or if adherence remains low.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREP ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••